# BLIS Technologies

the strain-science pioneer — Streptococcus salivarius K12 and M18, with four new peer-reviewed studies landed in the first half of 2026.


Source: https://cn.bioecon.ru/companies/blis-technologies/
Updated: 2026-07-28

- 国家: NZ

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 此前6轮融资 | https://media.businessdesk.co.nz/file/aGpn2i1H.pdf, https://media.businessdesk.co.nz/file/kd4wS4BP.pdf, https://new.nzx.com/announcements/473000, https://www.nzx.com/announcements/473000 |
| 产能 | Probi在华盛顿州Redmond具备BLIS K12及BLIS M18菌株散装粉末及产品应用的全规模生产能力 | https://www.probi.com/press-releases/2023/05/probi-takes-over-all-distribution-of-blis-k12-and-blis-m18-in-north-america/ |
| 认证 | 持有B Corp认证及MyGreen Lab认证 | https://blis.co.nz/press/most-studied-oral-probiotic-strains-for-dental-health-a-guide-to-the-clinical-evidence/, https://media.businessdesk.co.nz/file/aGpn2i1H.pdf |
| 监管批准 | BLIS K12和BLIS M18均持有美国GRAS身份 | https://blis.co.nz/press/most-studied-oral-probiotic-strains-for-dental-health-a-guide-to-the-clinical-evidence/ |
| 生产基地 | 新西兰但尼丁（生产基地） | https://aeroleads.com/c/blis-technologies-limited, https://blis.co.nz/facilities/ |
| 员工人数 | 约32名员工 | https://aeroleads.com/c/blis-technologies-limited |
| 营收 | 截至2026年3月31日止年度为$1470万 | https://media.businessdesk.co.nz/file/aGpn2i1H.pdf, https://media.businessdesk.co.nz/file/kd4wS4BP.pdf, https://new.nzx.com/announcements/473000, https://www.nzx.com/announcements/473000 |

独立来源: aeroleads.com, media.businessdesk.co.nz, new.nzx.com, nzx.com, probi.com

## 技术

- [口腔益生菌护理](https://cn.bioecon.ru/technology/probiotic-oral-care/)